Condition
Pressure Ulcers Stage II
Total Trials
5
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 4 (1)
Trial Status
Completed3
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05496296Not ApplicableRecruitingPrimary
Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries
NCT07193849Phase 4Recruiting
Zinc Oxide VS MEBO
NCT05130814Not ApplicableCompleted
EmoLED Medical Device Treatment of Second and Third Stage Pressure Ulcers
NCT05649332Not ApplicableCompleted
Study to Evaluate the Performance and Safety of the Medical Device Argogen
NCT02222454Not ApplicableCompletedPrimary
Safety Evaluation of the KLOX BioPhotonic System in Stage II and III Pressure Ulcers
Showing all 5 trials